Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease
Updated: 2024-04-24 22:00:00
An international consortium published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).